Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
- PMID: 7523700
- PMCID: PMC237204
- DOI: 10.1128/JVI.68.11.7570-7574.1994
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
Abstract
We have generated four mouse monoclonal antibodies (MAbs) to bovine papillomavirus virions that bound type-specific, adjacent, and conformationally dependent epitopes on the L1 major capsid protein. All four MAbs were neutralizing at ratios of 1 MAb molecule per 5 to 25 L1 molecules, but only three effectively blocked binding of the virus to the cell surface. Therefore, antibodies can prevent papillomavirus infection by at least two mechanisms: inhibition of cell surface receptor binding and a subsequent step in the infectious pathway. The neutralizing epitopes of the bovine papillomavirus L2 minor capsid protein were mapped to the N-terminal half of L2 by blocking the neutralizing activity of full-length L2 antiserum with bacterially expressed peptides of L2. In addition, rabbit antiserum raised against amino acids 45 to 173 of L2 had a neutralizing titer of 1,000, confirming that at least part of the N terminus of L2 is exposed on the virion surface.
Similar articles
-
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.J Virol. 2003 Aug;77(15):8386-93. doi: 10.1128/jvi.77.15.8386-8393.2003. J Virol. 2003. PMID: 12857908 Free PMC article.
-
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.Virology. 1997 Jan 20;227(2):474-83. doi: 10.1006/viro.1996.8348. Virology. 1997. PMID: 9018146
-
Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.Viruses. 2017 Nov 10;9(11):336. doi: 10.3390/v9110336. Viruses. 2017. PMID: 29125554 Free PMC article.
-
Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.Virology. 2007 May 10;361(2):435-46. doi: 10.1016/j.virol.2006.12.002. Epub 2007 Jan 12. Virology. 2007. PMID: 17222883 Free PMC article.
-
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6.J Virol. 1999 Jul;73(7):6188-90. doi: 10.1128/JVI.73.7.6188-6190.1999. J Virol. 1999. PMID: 10364381 Free PMC article.
Cited by
-
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.J Virol. 2013 Jun;87(11):6127-36. doi: 10.1128/JVI.03218-12. Epub 2013 Mar 27. J Virol. 2013. PMID: 23536682 Free PMC article.
-
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells.J Virol. 1995 Jun;69(6):3258-64. doi: 10.1128/JVI.69.6.3258-3264.1995. J Virol. 1995. PMID: 7745672 Free PMC article.
-
Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity.PLoS Pathog. 2014 Oct 16;10(10):e1004461. doi: 10.1371/journal.ppat.1004461. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25330199 Free PMC article.
-
Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.Arch Virol. 2006 Aug;151(8):1511-23. doi: 10.1007/s00705-006-0734-y. Epub 2006 Mar 3. Arch Virol. 2006. PMID: 16508703 Free PMC article.
-
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.PLoS One. 2013 Oct 4;8(10):e75677. doi: 10.1371/journal.pone.0075677. eCollection 2013. PLoS One. 2013. PMID: 24124504 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
